Use of miRNA Response Sequences to Block Off-Target Replication and Increase the Safety of an Unattenuated, Glioblastoma-Targeted Oncolytic HSV

Molecular Therapy - United States
doi 10.1038/mt.2014.177
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Corrigendum to “Use of miRNA Response Sequences to Block Off-Target Replication and Increase the Safety of an Unattenuated, Glioblastoma-Targeted Oncolytic HSV”

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

520. Arming a Tumor Targeted Oncolytic HSV Vector With MMP9 for Enhanced Distribution and Killing Activity

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2016English

Cancer: A Targeted Treatment With Off-Target Risks

Nature
Multidisciplinary
2017English

Methylphenidate Off-Label Use and Safety

SpringerPlus
Multidisciplinary
2014English

Systemic Oncolytic Cytokine HSV Therapy of Prostate Cancer

2007English

Participative Education for Children: An Effective Approach to Increase Safety Belt Use.

Journal of Applied Behavior Analysis
Applied PsychologyPhilosophySociologyPolitical Science
1990English

Temozolomide Resistance in Glioblastoma Occurs by miRNA-9-targeted PTCH1, Independent of Sonic Hedgehog Level

Oncotarget
Oncology
2015English

Response to Imatinib as a Function of Target Kinase Expression in Recurrent Glioblastoma

SpringerPlus
Multidisciplinary
2014English

Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress

Current Pharmaceutical Biotechnology
BiotechnologyPharmaceutical Science
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy